Cytosorbents (CTSO) Revenue (2011 - 2026)
Cytosorbents' (CTSO) quarterly Revenue came in at $8.9 million in Q1 2026, up 1.57% YoY from $8.7 million in Q1 2025, and down 4.01% on a QoQ basis from $9.2 million in Q4 2025.
Cytosorbents (CTSO) Revenue (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 16 years of Revenue data on file, last reported at $8.9 million in Q1 2026.
- Quarterly Revenue rose 1.57% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.2 million (up 5.28% YoY) and the FY2025 annual result came in at $37.1 million, up 4.12% from the prior year.
- Revenue declined to $8.9 million in Q1 2026, from $9.2 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $9.6 million in Q2 2025 to a low of $8.1 million in Q3 2022.
- A 5-year average of $9.0 million and a median of $8.9 million in 2026 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue fell 29.35% — and 2023, when it increased 10.89%.
- Tracing CTSO's Revenue over 5 years: stood at $9.4 million in 2022, then declined by 7.69% to $8.7 million in 2023, then increased by 5.57% to $9.2 million in 2024, then climbed by 0.91% to $9.2 million in 2025, then retreated by 4.01% to $8.9 million in 2026.
- The last three Revenue figures came in at $8.9 million (Q1 2026), $9.2 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 6.59 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 9.81 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 5.44 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 1.74 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 1.31 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 5.30 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 9.61 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Cytosorbents | 24.49 Mn | 20.08 Mn | 7.05 Mn | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Mar 31, 2026 | 8.86 Mn |
| Dec 31, 2025 | 9.23 Mn |
| Sep 30, 2025 | 9.49 Mn |
| Jun 30, 2025 | 9.62 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 9.15 Mn |
| Sep 30, 2024 | 8.61 Mn |
| Jun 30, 2024 | 8.84 Mn |
| Mar 31, 2024 | 8.99 Mn |
| Dec 31, 2023 | 8.67 Mn |
| Sep 30, 2023 | 8.81 Mn |
| Jun 30, 2023 | 9.42 Mn |
| Mar 31, 2023 | 9.45 Mn |
| Dec 31, 2022 | 9.39 Mn |
| Sep 30, 2022 | 8.11 Mn |
| Jun 30, 2022 | 8.50 Mn |
| Mar 31, 2022 | 8.69 Mn |
| Dec 31, 2021 | 10.78 Mn |
| Sep 30, 2021 | 9.76 Mn |